Europe Virgin Fund L.P. (‘EVF’), a private equity fund sponsored by Dragon Capital, has completed formation of a 50/50 joint venture {{{*}}} with Ucrafarma S.A., a Spanish pharmaceutical company. The partners have united their forces in Lux PHARMA Participations SA, a Luxembourg-based holding company, with Ucrafarma transferring various pharmaceutical assets including its 95% stake in… Continue Reading